These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 35721625)

  • 1. Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience.
    Johansen KL; Acharya A; Cizman B; Cobitz AR; Correa-Rotter R; Dasgupta I; Kher V; Lopes RD; Matsumoto L; Meadowcroft AM; Merege Vieira Neto O; Okabe M; Rayner B; Silva A; Thomas H; Singh AK
    Kidney360; 2022 Apr; 3(4):728-733. PubMed ID: 35721625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
    Tan AC; Ashley DM; Khasraw M
    Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conducting clinical trials during the COVID-19 pandemic.
    Collier EK; Hsiao JL; Shi VY
    J Dermatolog Treat; 2020 Jun; 31(4):330-332. PubMed ID: 32343162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis.
    Anderson M
    Bioanalysis; 2021 Aug; 13(15):1195-1203. PubMed ID: 34275327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown].
    Ghrieb Z; Allaoua S; Huang J; Langner N; François F; Maréchal C; Jebali M; Lebbé C; Chellah A; Bergeron A; Kiladjian JJ; Daltro De Oliveira R; Soret-Dulphy J; Benajiba L
    Therapie; 2021; 76(4):347-358. PubMed ID: 33640116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Anker SD; Butler J; Khan MS; Abraham WT; Bauersachs J; Bocchi E; Bozkurt B; Braunwald E; Chopra VK; Cleland JG; Ezekowitz J; Filippatos G; Friede T; Hernandez AF; Lam CSP; Lindenfeld J; McMurray JJV; Mehra M; Metra M; Packer M; Pieske B; Pocock SJ; Ponikowski P; Rosano GMC; Teerlink JR; Tsutsui H; Van Veldhuisen DJ; Verma S; Voors AA; Wittes J; Zannad F; Zhang J; Seferovic P; Coats AJS
    Eur Heart J; 2020 Jun; 41(22):2109-2117. PubMed ID: 32498081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
    Bausewein C; Hodiamont F; Berges N; Ullrich A; Gerlach C; Oechsle K; Pauli B; Weber J; Stiel S; Schneider N; Krumm N; Rolke R; Gebel C; Jansky M; Nauck F; Wedding U; van Oorschot B; Roch C; Werner L; Fischer M; Schallenburger M; Reuters MC; Schwartz J; Neukirchen M; Gülay A; Maus K; Jaspers B; Radbruch L; Heckel M; Klinger I; Ostgathe C; Kriesen U; Junghanß C; Lehmann E; Gesell D; Gauder S; Boehlke C; Becker G; Pralong A; Strupp J; Leisse C; Schloesser K; Voltz R; Jung N; Simon ST;
    BMC Palliat Care; 2022 Jan; 21(1):10. PubMed ID: 35027041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conducting Clinical Trials in the Time of a Pandemic.
    Beane JD; Dedhia PH; Ejaz A; Contreras CM; Cloyd JM; Tsung A; Pawlik TM
    Ann Surg; 2020 Sep; 272(3):e219-e221. PubMed ID: 32520739
    [No Abstract]   [Full Text] [Related]  

  • 12. Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response.
    Robison L; Cho Y; Viecelli AK; Johnson DW; Hawley CM; Valks A; Paul-Brent PA; Stastny R; Varghese J; Kiriwandeniya C; Pascoe EM; Vergara LA; Fahim MA; Boudville N; Krishnasamy R; Reidlinger D;
    Trials; 2021 Apr; 22(1):278. PubMed ID: 33853661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.
    Venkatakrishnan K; Yalkinoglu O; Dong JQ; Benincosa LJ
    Clin Pharmacol Ther; 2020 Oct; 108(4):699-702. PubMed ID: 32356569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Pandemic Impact on the National Health Care Surveys.
    Ward BW; Sengupta M; DeFrances CJ; Lau DT
    Am J Public Health; 2021 Dec; 111(12):2141-2148. PubMed ID: 34878878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care preparedness for the SARS-CoV-2 pandemic: a survey of NHS GPs.
    Pilbeam C; Edwards G; Tonkin-Crine S; Raymond M; Van Hecke O; Gobat N
    Fam Pract; 2022 May; 39(3):332-339. PubMed ID: 34871397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
    Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
    JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges.
    Piciocchi A; Messina M; Soddu S; La Sala E; Paoloni F; Giuliani G; Marino MR; Petrelli C; Gorreo Renzulli L; Fazi P; Vignetti M
    Br J Haematol; 2020 Aug; 190(4):e211-e214. PubMed ID: 32621754
    [No Abstract]   [Full Text] [Related]  

  • 19. Virtual laboratories during coronavirus (COVID-19) pandemic.
    Vasiliadou R
    Biochem Mol Biol Educ; 2020 Sep; 48(5):482-483. PubMed ID: 32722891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.